The goal of this study  is to understand how we can slow or reverse the emergence of AD symptoms

Contact information for the PREVENT-Alzheimer study

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

Neurocognitive studies by the McGill Group of Suicide Studies (MGSS) attempt to understand the link between the brain on one hand; and thoughts, emotions and behaviour on the other.

Not only does our environment influence our mental and physical health, it can also change the functioning of the genes we inherit at birth

Directed by Sylvain Williams, PhD, the lab is interested in two brain structures – the hippocampus and the septum – which interact closely in order to generate critical aspects of learning and memory.

The MGSS is made up of independent investigators, research associates, graduate PhD and MSc level students, and research collaborators.

Through research at PEPP, patients benefit from new knowledge, resulting in state-of-the-art diagnostic and treatment methods for the early stages of psychosis

Research at the Eating Disorders Program addresses various aspects of the phenomenology, etiology, and treatment of eating disorders in the spectrum of anorexia nervosa and bulimia nervosa.

A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal